Free Trial
CVE:CRM

CRH Medical (CRM) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.67 million shs
Average Volume
5.83 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CRM stock logo

About CRH Medical Stock (CVE:CRM)

CRH Medical Corporation (CRH) specializes in the distribution of medical products directly to physicians, particularly those in the gastroenterologist community. The Company's lead product, the CRH O'Regan System, is a single use, disposable, hemorrhoid treatment that is used in treating hemorrhoid grades I-IV. In addition to the product, CRH delivers clinical, marketing and operational support directly to its partner physicians. CRH utilizes its Web-based platform to connect doctors with patients, as well as educating its install base of physicians.

CRM Stock News Headlines

CRM Software Rating Methodology
Tips for Effectively Using Your CRM
BREAKING NEWS: AI Tech Now Used to Stop School Shooters
Two seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a shooter's exact location.
What Is Collaborative CRM? 2024 Guide
CRM Data: Types and Usage
What To Know About Your CRM and Location-Based Apps
CRM Automation: Best Practices and Definition
BREAKING NEWS: AI Tech Now Used to Stop School Shooters
Two seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a shooter's exact location.
Best Nonprofit CRM Software: 2024 Guide
CRH (CRH) Earnings Dates & Reports
CRM Mid Cap Value Instl
6 Best Healthcare CRM Software for 2024
CRM Ratings Methodology 2024
See More Headlines
Receive CRM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CRH Medical and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Software Publishers
Sub-Industry
Computer Software
CIK
N/A
Fax
N/A
Employees
73,500
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Anthony F. Holler M.D. (Age 63)
    Independent Chairman of the Board
  • Edward J. Wright
    Chief Executive Officer, Director
  • Richard K. Bear (Age 48)
    Chief Financial Officer
  • Jay Kreger
    President of CRH Anesthesia Management
  • David Johnson
    Independent Director
  • Bergein F. Overholt M.D.
    Independent Director
  • Todd R. Patrick (Age 48)
    Independent Director
  • Ian A. Webb (Age 61)
    Independent Director

CRM Stock Analysis - Frequently Asked Questions

How do I buy shares of CRH Medical?

Shares of CRM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of CRH Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CRH Medical investors own include Intel (INTC), Micron Technology (MU), PayPal (PYPL), Cisco Systems (CSCO), Dollar General (DG), Johnson & Johnson (JNJ) and AbbVie (ABBV).

This page (CVE:CRM) was last updated on 9/16/2024 by MarketBeat.com Staff

From Our Partners